Quick Answer
NOVAVAX INC reported Common Stock Shares Outstanding of 162.58 million shares for the year ending 2025.
- NOVAVAX INC showed an increase of +1.3% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from NOVAVAX INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 16 years of available data (2010 to 2025), NOVAVAX INC's Common Stock Shares Outstanding has grown by 46.4%.
- Historical annual values: Fiscal year 2025: 162.58 million shares | Fiscal year 2024: 160.42 million shares | Fiscal year 2023: 139.51 million shares | Fiscal year 2022: 86.04 million shares | Fiscal year 2021: 75.84 million shares | Fiscal year 2020: 70.95 million shares | Fiscal year 2019: 32.35 million shares | Fiscal year 2018: 19.22 million shares | Fiscal year 2017: 323.23 million shares | Fiscal year 2016: 271.25 million shares | Fiscal year 2015: 269.97 million shares | Fiscal year 2014: 238.83 million shares | Fiscal year 2013: 208.66 million shares | Fiscal year 2012: 147.94 million shares | Fiscal year 2011: 117.03 million shares | Fiscal year 2010: 111.04 million shares.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: